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Palmoplantar Keratoderma along with Neuromuscular
and Metabolic Phenotypes in Slurp1-Deficient Mice
Oludotun Adeyo1, Bernard B. Allan2, Richard H. Barnes II1, Chris N. Goulbourne1, Angelica Tatar1,
Yiping Tu1, Lorraine C. Young1, Michael M. Weinstein1, Peter Tontonoz3,4, Loren G. Fong1, Anne P. Beigneux1
and Stephen G. Young1,5
Mutations in SLURP1 cause mal de Meleda, a rare palmoplantar keratoderma (PPK). SLURP1 is a secreted protein
that is expressed highly in keratinocytes but has also been identified elsewhere (e.g., spinal cord neurons).
Here, we examined Slurp1-deficient mice (Slurp1 / ) created by replacing exon 2 with b-gal and neo cassettes.
Slurp1 / mice developed severe PPK characterized by increased keratinocyte proliferation, an accumulation of
lipid droplets in the stratum corneum, and a water barrier defect. In addition, Slurp1 / mice exhibited reduced
adiposity, protection from obesity on a high-fat diet, low plasma lipid levels, and a neuromuscular abnormality
(hind-limb clasping). Initially, it was unclear whether the metabolic and neuromuscular phenotypes were due to
Slurp1 deficiency, because we found that the targeted Slurp1 mutation reduced the expression of several
neighboring genes (e.g., Slurp2, Lypd2). We therefore created a new line of knockout mice (Slurp1X / mice)
with a simple nonsense mutation in exon 2. The Slurp1X mutation did not reduce the expression of adjacent
genes, but Slurp1X / mice exhibited all of the phenotypes observed in the original line of knockout mice. Thus,
Slurp1 deficiency in mice elicits metabolic and neuromuscular abnormalities in addition to PPK.
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INTRODUCTION
Mal de Meleda, a severe form of palmoplantar keratoderma
(PPK), is caused by mutations in SLURP1 (Fischer et al., 2001;
Eckl et al., 2003; Marrakchi et al., 2003). The disease is very
rare and there are relatively few thorough descriptions of
disease phenotypes (Fischer et al., 2001; Charfeddine et al.,
2003; Eckl et al., 2003; Marrakchi et al., 2003; Oh et al.,
2011). Affected patients have thickening of the skin on the
palms and soles, occasionally with pseudoainhum formation
and autoamputation of digits. The skin of the palms and soles
is often malodorous. Mal de Meleda patients have two
defective SLURP1 alleles; heterozygous carriers are normal.
The protein that is defective in mal de Meleda, SLURP1, is a
member of the ‘‘Lymphocyte Antigen 6’’ (Ly6) protein family.
The hallmark of Ly6 proteins is an B80-amino-acid domain
containing 10 cysteines, all disulfide-bonded and arranged
in a characteristic spacing pattern (Kieffer et al., 1994; Galat
et al., 2008). The same motif is found in cobra and viper
toxins, many of which target the neuromuscular acetylcholine
receptor (Fry et al., 2003; Galat et al., 2008). The majority
of mammalian Ly6 proteins are glycosylphosphatidylinositol
(GPI)-anchored proteins, but SLURP1 is a secreted protein.
SLURP1 is expressed at high levels in keratinocytes, with
particularly high levels in the palms and soles (Favre et al.,
2007). Because SLURP1 is secreted, it can be found in plasma
and urine (Andermann et al., 1999; Mastrangeli et al., 2003).
SLURP1 has also been found in rat spinal cord neurons
(Moriwaki et al., 2009).
There are many causes of PPK, and nearly all involve
defects in structural proteins of keratinocytes (Maestrini et al.,
1999; Heathcote et al., 2000; Richardson et al., 2006; Liu
et al., 2009; Bowden, 2010; Brooke et al., 2012; Petrof et al.,
2012; Xu and Nicholson, 2013). Mal de Meleda is unusual
in being caused by a secreted protein. Neither SLURP1’s
interactions with other proteins nor its role in epidermal
differentiation is fully understood, but SLURP1 was reported
to potentiate acetylcholine signaling through the a7 nicotinic
acetylcholine receptor (a7nAChR) (Chimienti et al., 2003).
Subsequent studies suggested that SLURP1 ‘‘ligation’’ to
a7nAChR leads to increased acetylcholine signaling, which
in turn leads to increased calcium signaling in keratinocytes
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and effects on kinase expression (Arredondo et al., 2005;
Chernyavsky et al., 2010). However, no one has yet tested
whether SLURP1 directly interacts with a7nAChR on the
surface of cells.
SLURP1 is one of nine Ly6 genes within an B550-kb
segment of human chromosome 8 (chromosome 15 in the
mouse). Only one of these genes, Gpihbp1, has been studied
in depth (Beigneux et al., 2007; Weinstein et al., 2008; Davies
et al., 2010; Beigneux et al., 2011). We showed that GPIHBP1,
a GPI-anchored protein of endothelial cells, is crucial for
plasma triglyceride metabolism; it binds lipoprotein lipase and
transports it to the capillary lumen (Beigneux et al., 2007;
Davies et al., 2010). Several other genes in this cluster (e.g.,
Slurp1, Slurp2, Ly6d) are expressed highly in keratinocytes.
Over the past few years, we have begun to investigate the
functional relevance of ‘‘Ly6 genes’’ near Gpihbp1. We had
dual motivations. One was to investigate the in vivo relevance
of Ly6 proteins in keratinocytes, and a second was to
determine whether other Ly6 genes, aside from Gpihbp1,
were relevant to metabolism. We began our studies with
Slurp1 because there were no published reports of Slurp1
knockout mice and we were intrigued by reports that SLURP1
is a small secreted protein that can be found in the plasma.
Our studies yielded fresh insights into SLURP1 function in the
skin and uncovered completely unexpected consequences of
Slurp1 deficiency in mice.
RESULTS
Slurp1 knockout mice, created by replacing exon 2 with
neo and lacZ cassettes (Supplementary Figure S1 online),
appeared normal at birth but developed PPK by 6 weeks of
age (Figure 1a–c). By hematoxylin and eosin staining, the
epidermis in Slurp1 / paw skin was thickened and the
stratum granulosum was poorly demarcated (Figure 1b). No
inflammatory infiltrates were present. The stratum corneum
contained abundant lipid droplets, as judged by hematoxylin
and eosin staining, BODIPY staining, and electron micro-
scopy (Figure 1c–e). Lamellar bodies were present in stratum
granulosum keratinocytes in both wild-type and Slurp1 /
mice, as determined by electron microscopy (Supplementary
Figure S2 online), but whether this technique is capable of
picking up subtle differences in the efficiency of lamellar
body secretion is uncertain. BrdU incorporation into kerati-
nocytes of paw skin in Slurp1 / mice was markedly
increased (Figure 1f). Aside from the paw, the skin and hair
of Slurp1 / mice were normal, both grossly and by routine
histology (Supplementary Figure S3 online). The gastrointest-
inal tract, bronchial epithelium, and lungs of Slurp1 / mice
were histologically normal. Humans with mal de Meleda
have been reported to have perivascular lymphocytic infil-
trates and perioral involvment (Bouadjar et al., 2000; Nath
et al., 2012), but these features were not present in Slurp1 /
mice. Slurp1þ / mice were indistinguishable from wild-type
mice.
SLURP1 could be documented in the paw skin of wild-type
mice but was absent in Slurp1 / mice (Figure 2a). Our
mouse SLURP1 antibodies were not useful for immunohisto-
chemistry (and the lacZ cassette was not expressed), making it
impossible to visualize SLURP1 expression in mouse skin.
However, a human SLURP1-specific antibody detected
SLURP1 in the suprabasal layers (including the spinous and
granular layers) of human skin (Figure 2c), confirming earlier
reports (Mastrangeli et al., 2003; Favre et al., 2007).
Because SLURP1 is expressed in the stratum granulosum of
human skin (the layer that creates the water barrier) and also
because of the accumulation of lipids in the stratum corneum
of Slurp1 / mice, we assessed transepidermal water loss in
Slurp1 / and wild-type mice. Water loss from the paw skin
of Slurp1 / mice was significantly greater than in wild-type
mice, but water loss from the skin on the ear and back was
similar in the two groups of mice (Figure 3).
Slurp1 / mice exhibited a neuromuscular phenotype:
they clasped their hind limbs when picked up by the tail (a
phenotype often observed in the setting of central nervous
system disease, myopathy, or peripheral neuropathy)
(Hayward et al., 2008; Dequen et al., 2010; Lalonde and
Strazielle, 2011) (Figure 4a and b). The sciatic nerve of
Slurp1 / mice was normal by routine histology and by
electron microscopy (Supplementary Figure S4 online), and no
pathology was observed in the cerebral cortex or cerebellum.
Serum chemistries in Slurp1 / mice, including creatine
phosphokinase levels, were within normal limits.
Slurp1 / mice also exhibited metabolic phenotypes; they
had reduced body weight and adiposity on a chow diet,
despite consuming more food (Figure 4c–e). They were also
protected from obesity on a high-fat diet (Figure 4f–g). The
plasma levels of triglycerides, cholesterol, insulin, and leptin
were lower in Slurp1 / mice than in wild-type littermate
controls (Figure 5a–c). Metabolic cage studies showed that
mean O2 consumption and CO2 production were higher in
Slurp1 / mice; the respiratory quotient was higher in
Slurp1 / mice during the dark phase (Figure 5d–f and
Supplementary Figure S5A–C online). Surprisingly, physical
activity in Slurp1 / mice was lower, as judged by laser
beam breaks in metabolic cages (Figure 5g and Supplementary
Figure S5D online). We considered the possibility that
hyperventilation might contribute to increased oxygen
consumption, but this appeared unlikely because the serum
bicarbonate levels were within normal limits (13.6±
0.56 mEq l1 in wild-type mice and 11.55±2.30 mEq l 1 in
Slurp1 / mice). It is conceivable that increased grooming in
Slurp1 / mice (a form of activity that might not lead to laser
beams breaks) could account for the increased
oxygen consumption, but studies of grooming behavior in
Slurp1 / mice with continuous video monitoring provided
no evidence that this was the case.
We suspected that the metabolic abnormalities would be
accompanied by gene-expression perturbations in peripheral
tissues. Hormone-sensitive lipase (HSL) and adipose triglycer-
ide lipase (ATGL) were increased in brown and white adipose
tissue (Supplementary Figure S6 online). In addition, PGC-1a
expression was higher in the soleus muscle, liver, and heart of
Slurp1 / mice (Supplementary Figure S6 online), and the
expression of the fatty acid transport protein (FATP-1), which
has an important role in facilitating mitochondrial fatty acid
oxidation (Sebastian et al., 2009; Wiczer and Bernlohr, 2009),
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was increased in the quadriceps, soleus, brown adipose
tissue, and white adipose tissue (Supplementary Figure S6
online). UCP1 expression in brown adipose tissue was
similar in Slurp1 / and wild-type mice (Supplementary
Figure S6 online).
Because the neuromuscular and metabolic phenotypes
were unexpected, we were worried that the targeted Slurp1
mutation, which involved insertions of b-gal and neo cas-
settes, might have influenced the expression of neighboring
genes (Olson et al., 1996). Indeed, the expression of two Ly6
genes adjacent to Slurp1 (Slurp2 and Lypd2) was reduced by
60–75% in Slurp1 / mice, whereas the expression of a
more distant Ly6 family member, Ly6d, was unaffected
(Supplementary Figure S7A online). Perturbed expression of
Slurp2 and Lypd2 was also present in Slurp1þ / mice,
where the paw skin is normal, implying that the effects of
the targeted Slurp1 mutation on neighboring genes were due
to effects on chromatin structure and not due to an indirect
consequence of PPK.
The fact that the Slurp1 mutation lowered the expression
of nearby genes suggested that the ‘‘non-PPK’’ phenotypes
in Slurp1 / mice might be due to altered expression of
neighboring genes rather than to SLURP1 deficiency. To
address that possibility, we created new Slurp1 knockout mice
harboring only a simple nonsense mutation (Supplementary
Figure S7B–D online). This allele, designated Slurp1X, did not
lower the expression of adjacent genes (Supplementary Figure
S7E online). Nevertheless, homozygous knockout mice
(Slurp1X / ) exhibited all of the phenotypes found in the
original Slurp1 / mice (PPK, reduced body weight, hind-
limb clasping) (Figure 6). In fact, the neuromuscular abnorm-
alities were more striking in Slurp1X / mice; aside from
hind-limb clasping, they dragged their hind limbs and tail by
4 months of age (Supplementary Movies 1 and 2 online).
DISCUSSION
In the current study, we investigated Slurp1 knockout mice,
fully expecting to encounter PPK. That expectation was
(SC)
50 µm 50 µm
(SC)
Slurp1–/–Slurp1+/+
Figure 1. Palmoplantar keratoderma and increased stratum corneum lipid droplets in Slurp1 / mice. (a) Paws from wild-type and Slurp1 / mice, revealing
markedly thickened skin in Slurp1 / mice. (b, c) Hematoxylin and eosin–stained sections revealing a thickened epidermis in the paw skin of a Slurp1 /
mouse, along with many tiny lipid droplets in the stratum corneum (arrowheads). Bars ¼ 50mm and 10mm for b and c, respectively. (d) BODIPY 493/503 (green)
staining showing lipid droplets in the stratum corneum (SC) of the paw skin of a Slurp1 / mouse. DNA is stained with DAPI (blue). Bar¼ 50mm. (e) Electron
micrograph showing lipid droplets in the stratum corneum of Slurp1 / paw skin (arrowheads). Bar¼ 1mm. (f) Increased BrdU incorporation into DNA of paw
keratinocytes of Slurp1 / mice (green). DNA is stained with DAPI (red). Bar¼ 50mm.
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fulfilled, but we also found neuromuscular and metabolic/
body-weight abnormalities. Initially, whether SLURP1 defi-
ciency caused the ‘‘non-PPK’’ phenotypes seemed uncertain
because the targeted mutation, which involved insertions of b-
gal and neo cassettes, lowered the expression of nearby genes.
However, a new line of Slurp1 knockout mice harboring a
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Figure 2. Immunochemical detection of SLURP1. (a) Western blot of extracts of paw skin from wild-type (Slurp1þ /þ ) and Slurp1 / mice with an antibody
against a mouse SLURP1 peptide. CHO cells transfected with a flag-tagged mouse SLURP1 expression vector were used as a control. SLURP1, similar to nearly all
other Ly6 proteins, has an N-linked glycosylation site, and the two SLURP1 bands probably reflect glycosylated and nonglycosylated versions of the protein
(Beigneux et al., 2008). The SLURP1 antibody did not cross-react with SLURP2. (b) The specificity of the human SLURP1 antibody (green) in these studies was
assessed by immunocytochemistry. CHO-K1 cells were transiently transfected with an empty vector or an S-protein–tagged human SLURP1 expression vector.
Cells that had been transiently transfected with the S-protein–tagged SLURP1 vector were identified with an S-protein–specific antibody (red). (c) Detection of
SLURP1 (green) in human skin by immunohistochemistry with a human SLURP1 antibody. Keratin 14 (red) was used as a marker of basal keratinocytes; DNA was
stained with DAPI (blue). Bars¼20mm.
O Adeyo et al.
Unexpected Phenotypes in Slurp1-Deficient Mice
1592 Journal of Investigative Dermatology (2014), Volume 134
simple nonsense mutation—and where the expression of
surrounding genes was normal—displayed the same neuro-
muscular and metabolic phenotypes, leaving no doubt that the
‘‘non-PPK’’ phenotypes were bona fide features of SLURP1
deficiency. We considered the possibility that the unexpected
phenotypes could be due to ‘‘passenger genes’’ segregating
with Slurp1 (Smithies and Maeda, 1995), but this explanation
is highly unlikely because neuromuscular and body-weight
phenotypes are absent in chow-fed knockout mice for nearby
Ly6 genes (Lynx1 and Gpihbp1) (Ibanez-Tallon et al., 2002;
Miwa et al., 2006; Beigneux et al., 2007; Weinstein et al.,
2010a, b; Weinstein et al., 2012).
Why a deficiency of SLURP1, a secreted Ly6 protein, causes
PPK is uncertain, but one possibility, suggested by Fischer
et al. (2001), is that SLURP1 is a ligand for a cell-surface
receptor on keratinocytes. Chimienti et al. (2003) reported
that SLURP1 potentiates calcium flow mediated by the
a7 nicotinic acetylcholine receptor (a7nAChR). In addition,
Arredondo et al. (2005) reported that SLURP1 competitively
inhibits binding of small-molecule ligands to that receptor.
The involvement of acetylcholine receptors in the
pathogenesis of mal de Meleda is potentially attractive
because acetylcholine signaling is thought to be important in
multiple aspects of keratinocyte biology and because the
three-fingered structure of SLURP1 resembles cobra toxins
that bind to acetylcholine receptors at the neuromuscular
junction (Andermann et al., 1999; Fischer et al., 2001; Kini,
2002). In addition, a ‘‘SLURP1–acetylcholine connection’’
could potentially be relevant to both the skin and
neuromuscular phenotypes of Slurp1 / mice. At this point,
what is needed is firm evidence for specific protein–protein
interactions between SLURP1 and acetylcholine receptors.
Thus far, we have not been successful in documenting
SLURP1 binding to a7nAChR on the surface of CHO-K1 cells
using the same cell-based binding assays that have been used
extensively to document the binding of a protein ligand to
GPIHBP1 (an Ly6 protein that is structurally related to
SLURP1) (Beigneux et al., 2009; Franssen et al., 2010;
Olafsen et al., 2010; Beigneux et al., 2011; Voss et al.,
2011). However, it is possible that our cell-based binding
assays were not sufficiently sensitive to detect SLURP1–
a7nAChR interactions. In addition, we have not yet tested
the possibility that SLURP1 might bind to other acetylcholine
receptors. In any case, we believe that a ‘‘SLURP1–
acetylcholine receptor connection’’ is an attractive concept
and deserves further study. We also believe that it is important
to be open to other possibilities for SLURP1 function. One is
that SLURP1 binds to and modifies the function of structural
proteins already implicated in the pathogenesis of PPK, for
example, demosomal proteins (Richardson et al., 2006; Liu
et al., 2009; Bowden, 2010; Brooke et al., 2012; Petrof et al.,
2012) or connexin 26, a gap junction protein (Maestrini et al.,
1999; Heathcote et al., 2000; Xu and Nicholson, 2013). The
idea that SLURP1 might affect cell–cell junctions has been
raised previously (Fischer et al., 2001) and is not farfetched
because another Ly6 protein, LY6D, is present in desmosomes
(Brakenhoff et al., 1995; Fischer et al., 2001). In addition,
Drosophila Ly6 proteins are crucial for the septate junctions
that cement epithelial cells together (Hijazi et al., 2009; Nilton
et al., 2010; Hijazi et al., 2011; Kim and Marques, 2012).
The mechanism by which SLURP1 deficiency elicits the
neuromuscular findings is unknown. One possibility is that
SLURP1 has a role in peripheral nerves, perhaps (as suggested
by Moriwaki et al. (2009)) by acting as a neurotransmitter.
Improved antibody reagents will be required to investigate this
possibility. A more speculative idea relates to the possible
involvement of SLURP1 in cell–cell junctions in peripheral
nerves (Banerjee et al., 2006). Genetic manipulations of axo-
glial septate junction proteins in mice alter nerve conduction
and elicit the same hind-limb clasping phenotype found in
Slurp1 / mice (Cifuentes-Diaz et al., 2011; Lee et al., 2013).
No one has yet reported neuropathy in mal de Meleda
patients, but we would not be surprised if sophisticated
testing were to uncover subtle abnormalities.
SLURP1 deficiency reduced body weight and adiposity,
increased oxygen consumption, and lowered plasma lipid and
insulin levels. The same phenotypes have been observed
in mice lacking stearoyl-CoA desaturase-1 (SCD1), which is
required for lipid synthesis and for the formation of the
epidermal water barrier (Binczek et al., 2007; Sampath
et al., 2009). Scd1 knockout mice display increased
evaporative water loss, leading to the loss of body heat and
increased energy expenditure (Binczek et al., 2007). We doubt
that the same mechanism applies in Slurp1 / mice. First, the
water barrier defect in Slurp1 / mice is confined to the paw,
and it seems unlikely that water loss from this tiny area of skin
would explain the striking metabolic abnormalities. Second,
Slurp1 deficiency did not increase the expression of
thermogenic genes in brown adipose tissue. Third, reduced
body weight is not a general feature of PPK; grainy head-like 1
knockout mice have severe PPK but no alterations in body
weight (Wilanowski et al., 2008).
Although body-weight and adiposity abnormalities in
SLURP1-deficient mice are profound, the underlying
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Figure 3. Evaporative water loss from the paw, ear, and back skin of
Slurp1þ /þ and Slurp1 / mice. Measurements of evaporative water loss
were performed with an RG1 evaporimeter (n¼ 6 per group). TEWL,
transepidermal water loss. ***Po0.001.
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mechanisms are not clear. It is tempting to speculate
that SLURP1, a secreted peptide found in the plasma, may
act directly or indirectly to increase fuel utilization in
metabolically active tissues. We did observe increased expres-
sion of HSL and ATGL (genes involved in intracellular
lipolysis) in adipose tissues of Slurp1 / mice; we also found
increased Pgc1a and Fatp1 expression in multiple tissues of
Slurp1 / mice.
We found an accumulation of neutral lipid droplets in the
stratum corneum of paw skin of Slurp1 / mice. In earlier
studies, lipid droplets were observed in the fingernails of mal
de Meleda patients (Salamon et al., 1984; Salamon, 1986),
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Figure 4. ‘‘Non-skin’’ phenotypes in Slurp1 / mice. (a) Hind-limb clasping in male Slurp1 / mice when picked up by the tail (similar results were observed
with female Slurp1 / mice). (b) Quantification of the hind-limb clasping phenotype (0 for no hind-limb retraction, 1 for unilateral retraction, 2 for bilateral
retraction) (n¼ 16 for Slurp1þ /þ ; n¼ 19 for Slurp1þ / ; and n¼ 17 for Slurp1 / mice). ***Po0.001 (Slurp1þ /þ versus Slurp1 / ). (c) Weight gain in chow-fed
female Slurp1þ /þ and Slurp1 / mice (4–15 weeks of age; n¼ 11 per group). Similar results were observed with male mice. (d) Reduced adiposity in 7-month-
old chow-fed female Slurp1 / mice, as judged by NMR (n¼ 5 per group). (e) Food consumption in male Slurp1þ /þ and Slurp1 / mice over 24 hours. Similar
results were observed in two independent experiments (n¼ 3 mice per group per experiment). (f) Slurp1 / mice are resistant to diet-induced obesity. Female
Slurp1 / (n¼4) and Slurp1þ /þ mice (n¼3) were fed a high-fat diet for 11 weeks and weight gain was analyzed. Similar results were observed with male mice.
*Po0.05; **Po0.01; ***Po0.001. (g) Consumption of the high-fat diet (HFD) by Slurp1þ /þ and Slurp1 / mice over 24 hours (n¼ 3 per group).
O Adeyo et al.
Unexpected Phenotypes in Slurp1-Deficient Mice
1594 Journal of Investigative Dermatology (2014), Volume 134
and higher triglyceride levels were also found in the epidermis
of several mal de Meleda patients (Kuster et al., 2003). The
increased numbers of lipid droplets in the stratum corneum
are likely due to impaired hydrolysis of triglycerides, a process
that is essential for the formation of acylceramides and
the epidermal water barrier (Elias et al., 2008). A similar
accumulation of neutral lipid droplets in the stratum corneum
is found in neutral lipid storage disease owing to CGI-58
deficiency (Demerjian et al., 2006), where triglyceride
hydrolysis is clearly impaired (Radner et al., 2010; Ujihara
et al., 2010; Radner et al., 2011). We did not find reduced
transcript levels for CGI-58, ATGL, triglyceride hydrolase K, or
triglyceride hydrolase N in paw skin of Slurp1 / mice (not
shown). Nevertheless, it seems likely that SLURP1 deficiency
influences the efficiency of triglyceride hydrolysis in
keratinocytes, perhaps indirectly as a consequence of altered
keratinocyte proliferation or differentiation.
Our findings are relevant to clinical dermatology. The
discovery of a defective water barrier in SLURP1-deficient
skin, along with increased neutral lipids in the stratum
corneum, could help explain malodorous skin in mal de
Meleda (Oh et al., 2011). Leakage of interstitial fluids into
the stratum corneum along with the accumulation of trigly-
ceride droplets would favor the growth of microorganisms,
and bacterial lipases are known to release malodorous
aldehydes, alcohols, and ketones (Chung and Seok, 2012).
In addition, our studies reinforce the fact that genetic defects
causing PPK can be accompanied by ‘‘non-skin’’ disease
phenotypes. Other genetic defects causing PPK are associated
with deafness, right ventricular dysplasia, and central nervous
system disease (Heathcote et al., 2000; Brooke et al., 2012;
Petrof et al., 2012; Xu and Nicholson, 2013). In the current
studies, we found that SLURP1 deficiency in the mouse leads
to neuromuscular and body-weight abnormalities.
MATERIALS AND METHODS
Slurp1-deficient mice
Slurp1 / mice were obtained from Lexicon (The Woodlands, TX).
The Slurp1 knockout allele was detected by PCR genotyping, as
described in the Supplementary Methods online. Slurp1X mice were
created by introducing a premature stop codon into exon 2 (N35X), as
described in the Supplementary Methods online and Supplementary
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Figure 5. Altered metabolic parameters in Slurp1 / mice. Plasma levels of cholesterol and triglycerides (males, n¼ 10 per group) (a), insulin (males, n¼ 9 wild-
type mice; n¼ 10 Slurp1 / mice) (b), and leptin (males, n¼ 6 wild-type mice; n¼ 4 Slurp1 / mice) (c) in wild-type and Slurp1 / mice. *Po0.05;
***Po0.001. (d) Metabolic cage studies revealing increased oxygen consumption (VO2) in male Slurp1 / mice. (e) CO2 production. (f) Respiratory quotient
measurements during two dark and light cycles. (g) Decreased activity in male Slurp1 / mice. Bar graph showing total activity (the sum of X Total, X
Ambulatory, and Z Total). X Total, total counts of beam interference in the x dimension, including stationary positions; X Ambulatory, multiple beam breaks in the
x dimension; Z Total, line breaks in the z dimension (rearing up) (n¼ 3 per group). Similar results were observed in two independent experiments. **Po0.01;
***Po0.001.
O Adeyo et al.
Unexpected Phenotypes in Slurp1-Deficient Mice
www.jidonline.org 1595
Figure 6 online. All mice had a mixed genetic background (o10%
129/Sv and 490% C57BL/6). Unless otherwise specified, the mice
were fed a chow diet (LabDiet No. 5001, Purina, Brentwood, MO)
and housed in a barrier facility with a 12-h light/dark cycle. All
studies were approved by UCLA’s Animal Research Committee.
Histology and immunofluorescence microscopy
Skin biopsies were fixed overnight in 10% formalin, embedded in
paraffin, sectioned, and stained with hematoxylin and eosin. For
immunohistochemistry, cultured cells and frozen sections of human
skin were fixed in methanol. The cells and tissues were blocked with
10% donkey serum and incubated with primary antibodies at 4 1C
overnight. Antibodies included a goat polyclonal antibody against the
S-protein tag (Abcam, Cambridge, MA; 1:500), a mouse antiserum
against human SLURP1 (Novus Biologicals, Littleton, CO; 1:100), a rat
monoclonal antibody against BrdU (Abcam; 1:200), or an Alexa 568–
labeled mouse monoclonal antibody against cytokeratin 14 (Abcam;
1:500). Secondary antibodies included an Alexa 568–conjugated
donkey anti-goat IgG (Invitrogen, Grand Island, NY; 1:800), an Alexa
488–conjugated donkey anti-mouse IgG (Invitrogen; 1:800), and an
Alexa 488–conjugated donkey anti-rat IgG (Invitrogen; 1:200). DNA
was visualized with DAPI. Microscopy was performed with an
Axiovert 200M microscope.
Western blotting
Proteins from tissue or cell culture extracts (25mg) were size-
fractionated on a 12% Bis-Tris SDS-polyacrylamide gel and then
transferred to nitrocellulose membranes. Antibodies included a mouse
monoclonal antibody against b-actin (1:500) (Abcam, Cambridge,
MA), a rabbit antiserum against a SLURP1 peptide (CKTVLET-
VEAAFPFNHSPMVTRS) (5mg ml 1), and an IRdye800-conjugated
donkey anti-rabbit and donkey anti-mouse IgG (1:2,000) (Li-Cor,
Lincoln, NE). Antibody binding was detected with an Odyssey infrared
scanner (Li-Cor).
Quantification of transepidermal water loss
Transepidermal water loss (TEWL) measurements on the skin
of the back, rear paws, and ear were recorded at room temperature
on age- and sex-matched wild-type and Slurp1 / mice (n¼ 6 per
group) with an RG1 evaporimeter (cyberDERM, Broomall, PA)
equipped with a 0.3-mm circular adaptor. The hair on a small
portion of the back was shaved with a clipper before TEWL
measurements were performed.
Body-weight/metabolic phenotypes
Body weights of male and female mice were recorded weekly from
4 to 15 weeks of age, and measurements of adiposity were made
by NMR (Weinstein et al., 2010a). Measurements of oxygen
consumption and respiratory quotient were performed using sealed
metabolic cages (Oxymax, Columbus Instruments, Columbus, OH)
(Weinstein et al., 2012). Sensors attached to the sealed chamber
measured oxygen and carbon dioxide concentrations, and physical
activity was assessed by the number of laser beam breaks. Data were
collected and analyzed with the Oxymax/CLAMS software. All
metabolic cage studies were conducted using male mice.
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Figure 6. Slurp1X / mice exhibit PPK and the same ‘‘non-skin’’ disease
phenotypes observed in the original line of Slurp1 knockout mice.
(a, b) Paws of male Slurp1Xþ /þ and Slurp1X / mice at 12 weeks of age.
(c, d) Hematoxylin and eosin–stained sections revealing a thickened epidermis
in the paw skin of a Slurp1X / mouse. Higher-powered images revealed
many small lipid droplets in the stratum corneum (arrowhead). Bar¼ 50mm.
(e, f) Hind-limb clasping in a male Slurp1X / mouse. Similar results were
observed with female mice. (g) Reduced body weight in Slurp1X / mice.
Serial measurements of body weight revealed a 15–20% reduction in
body weight in 9-week-old Slurp1X / female mice on chow diet, very
similar to findings in the original line of Slurp1 knockout mice. *Po0.05;
***Po0.001.
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